Prosigna Breast Cancer Assay Now Approved for Reimbursement in Germany
Go back to Prosigna Breast Cancer Assay Now Approved for Reimbursement in Germany| VERACYTE (NASDAQ: VCYT) | Delayed: 42.19 +1.51 (3.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.68 | 52 Week High | $8.45 | |||
| Open | $41.92 | 52 Week Low | $4.21 | |||
| Day High | $42.52 | P/E | N/A | |||
| Day Low | $40.10 | EPS | $-1.52 | |||
| Volume | 1,761,588 | |||||
